🥇 First rule of investing? Know when to save! Up to 55% off InvestingPro before BLACK FRIDAYCLAIM SALE

South Divided Over Cannabis Legalization: Who's Against Safe Drug Consumption Sites & More Marijuana Regulatory Updates

Published 17/04/2023, 17:41
© Reuters.  South Divided Over Cannabis Legalization: Who's Against Safe Drug Consumption Sites & More Marijuana Regulatory Updates
ICON
-

Benzinga - PA Dems Against Safe Drug Consumption Sites

  • Four Pennsylvania lawmakers seek to end a push to launch operations in a safe drug consumption site.
  • With the move, Sens. Sharif Street (D), Christine Tartaglione (D), Anthony Williams (D) and Jimmy Dillon (D) submitted an amicus brief to the U.S. District Court for the Eastern District of Pennsylvania fighting against any agreement in a lawsuit that seeks to allow operations of a center in Philadelphia that non-profit Safehouse would run.
South Divided Over Cannabis Legalization
  • Two recent polls have investigated the sentiment on cannabis legalization in two Southern states. The survey from Winthrop University has revealed that residents of South Carolina support legalization of both recreational and medical use of cannabis, with 56% and 76%, respectively, backing the reform, reported Marijuana Moment.
  • Congresswoman Nancy Mace, serving as the U.S. representative for South Carolina's 1st congressional district since 2021 and has been a cannabis reform advocate for years, said in last week's tweet that findings are "not as controversial as some would have you to believe."
  • Kentuckians are, to that end, more conservative, as a recent Emerson College poll found that the state's Republican voters are not supporting recreational marijuana legalization. The majority (50.2%) is openly against it, while a third of those asked would support the cannabis policy reform.
Kentucky Researchers To Study Pros & Cons Of Medical Marijuana
  • On the heels of the Bluegrass State making the headlines as the 38th state in the nation to enable access to medical marijuana for patients with debilitating conditions, researchers from the University of Kentucky are getting ready to research the pros and cons of the medical use of the plant.
  • The state granted the research center $2 million to conduct the study last year. The researchers aim to study the effects of cannabis on opioid addiction, obesity and cancer.
  • "We are looking at outcomes like quality of life, mood and appetite," Dr. Shanna Babalonis, director of the University of Kentucky Cannabis Center, said. "We are looking at weight, so we are trying to figure out will medical marijuana and cannabis help the patients keep their weight up."
WA Bill To Legalize Interstate Marijuana Sales Heads To Governor
  • A bill allowing cannabis companies to negotiate interstate agreements in Washington State is heading to Gov. Jay Inslee's (D) desk after the state Senate gave it final approval on Friday.
  • The bill, SB 5069 from Sen. Ann Rivers (R), got the green light from members of the House of Representatives on Wednesday following the adoption of an amendment that sought to change "a scrivener's error" in the bill's version that passed the state Senate in a 40-8 vote last month.
  • Under the legislation, imported cannabis goods would have to be aligned with the state's testing, packaging and labeling regulations; they need to adapt to rules set by the Department of Health and Liquor & Cannabis Board.
Photo: Benzinga edit of photo by Shutterstock

© 2023 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Read the original article on Benzinga

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.